rs797045091
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_017547.4(FOXRED1):c.612_615dup(p.Ala206SerfsTer15) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000311 in 1,613,142 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00033 ( 0 hom. )
Consequence
FOXRED1
NM_017547.4 frameshift
NM_017547.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.28
Genes affected
FOXRED1 (HGNC:26927): (FAD dependent oxidoreductase domain containing 1) This gene encodes a protein that contains a FAD-dependent oxidoreductase domain. The encoded protein is localized to the mitochondria and may function as a chaperone protein required for the function of mitochondrial complex I. Mutations in this gene are associated with mitochondrial complex I deficiency. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
?
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
?
Very rare variant in population databases, with high coverage;
PP5
?
Variant 11-126275000-G-GGAGT is Pathogenic according to our data. Variant chr11-126275000-G-GGAGT is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 95754.We mark this variant Likely_pathogenic, oryginal submissions are: {Pathogenic=11, Likely_pathogenic=2, Uncertain_significance=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FOXRED1 | NM_017547.4 | c.612_615dup | p.Ala206SerfsTer15 | frameshift_variant | 5/11 | ENST00000263578.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FOXRED1 | ENST00000263578.10 | c.612_615dup | p.Ala206SerfsTer15 | frameshift_variant | 5/11 | 1 | NM_017547.4 | P3 |
Frequencies
GnomAD3 genomes ? AF: 0.000131 AC: 20AN: 152158Hom.: 0 Cov.: 31
GnomAD3 genomes
?
AF:
AC:
20
AN:
152158
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000227 AC: 57AN: 251338Hom.: 0 AF XY: 0.000206 AC XY: 28AN XY: 135890
GnomAD3 exomes
AF:
AC:
57
AN:
251338
Hom.:
AF XY:
AC XY:
28
AN XY:
135890
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000330 AC: 482AN: 1460866Hom.: 0 Cov.: 30 AF XY: 0.000282 AC XY: 205AN XY: 726824
GnomAD4 exome
AF:
AC:
482
AN:
1460866
Hom.:
Cov.:
30
AF XY:
AC XY:
205
AN XY:
726824
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.000131 AC: 20AN: 152276Hom.: 0 Cov.: 31 AF XY: 0.000107 AC XY: 8AN XY: 74468
GnomAD4 genome
?
AF:
AC:
20
AN:
152276
Hom.:
Cov.:
31
AF XY:
AC XY:
8
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:13Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 03, 2023 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 22200994, 30956948, 31589614, 33613441, 30723688, 31065540) - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 25, 2024 | This sequence change creates a premature translational stop signal (p.Ala206Serfs*15) in the FOXRED1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FOXRED1 are known to be pathogenic (PMID: 20818383, 20858599). This variant is present in population databases (rs765593341, gnomAD 0.07%). This premature translational stop signal has been observed in individuals with mitochondrial complex I deficiency (PMID: 22200994, 31065540). ClinVar contains an entry for this variant (Variation ID: 95754). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 12, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2017 | - - |
Mitochondrial complex 1 deficiency, nuclear type 19 Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Jan 16, 2019 | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PP5. - |
Pathogenic, criteria provided, single submitter | clinical testing | New York Genome Center | May 07, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Apr 24, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Apr 20, 2022 | - - |
Mitochondrial complex I deficiency, nuclear type 1 Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Sep 22, 2017 | The FOXRED1 c.612_615dupAGTG (p.Ala206SerfsTer15) variant results in a frameshift variant predicted to result in premature termination of the protein. The p.Ala206SerfsTer15 variant has been reported in one individual with mitochondrial complex I deficiency in a compound heterozygous state with a known likely pathogenic missense variant (Haack et al. 2012). The age of onset of disease in this individual was before six months of age, with the disease course described as progressive. The individual was reported to have less than 25% of complex 1 activity compared to controls. The p.Ala206SerfsTer15 variant was also identified in one healthy individual in a heterozygous state (Vassy et al. 2017). The p.Ala206SerfsTer15 variant was absent from 200 control chromosomes and is reported at a frequency of 0.00069 in the Ashkenazi Jewish population of the Genome Aggregation Database. Based on the evidence and the potential impact of frameshift variants, the p.Ala206SerfsTer15 variant is classified as a variant of unknown significance but suspicious for pathogenicity for mitochondrial complex I deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, criteria provided, single submitter | clinical testing | DASA | Jan 05, 2022 | The c.612_615dup;p.(Ala206Serfs*15) is a null frameshift variant (NMD) in the FOXRED1 gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevantexon to the transcript -PVS1. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 95754; PMID: 33613441; 31065540; 22200994; 30723688; 30956948; 31589614) - PS4. The variant is present at low allele frequencies population databases (rs398124308– gnomAD 0.01314%; ABraOM 0.000427 frequency - http://abraom.ib.usp.br/) - PM2_supporting. The p.(Ala206Serfs*15) was detected in trans with a pathogenic variant(PMID: 22200994, 30723688, 31065540) - PM3. In summary, the currently available evidence indicates that the variant is pathogenic. - |
Mitochondrial complex I deficiency Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 08, 2014 | The Ala206SerfsX15 variant has been identified in 0.012% (1/8254) of European American chromosomes and 0.023% (1/4264) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/). The same frameshift variant (but from a different nucleotide variant) in FOXRED1 has been reported in 1 individual with mitochondrial complex I deficiency (Haack 2012). This individual was compound heterozygous. The Ala206SerfsX15 frameshift variant is predicted to alter the protein’s amino acid sequence beginning at position 206 and lead to a premature termination codon 15 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. In summary, this variant is likely to be pathogenic, though additional data are required to fully establish the role of the FOXRED1 gene in disease given limited studies to date. - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 25, 2022 | The c.612_615dupAGTG (p.A206Sfs*15) alteration, located in exon 5 (coding exon 5) of the FOXRED1 gene, consists of a duplication of AGTG at position 612, causing a translational frameshift with a predicted alternate stop codon after 15 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This alteration has been detected with another mutation in patients with FOXRED1-related mitochondrial complex I deficiency (Ahmed, 2017; Apatean, 2019; Haack, 2012). Based on the available evidence, this alteration is classified as pathogenic. - |
Leigh syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 24, 2016 | Variant summary: The FOXRED1 c.612_615dupAGTG (p.Ala206Serfs) variant results in a premature termination codon, predicted to cause a truncated or absent FOXRED1 protein due to nonsense mediated decay (NMD), which are commonly known mechanisms for disease. If NMD is escaped, this variant is predicted to truncate Glycine/D-amino acid oxidase domain. Truncation downstream of this position has also been reported (PMID: 20818383). This variant was found in 24/120958 control chromosomes at a frequency of 0.0001984, which does not exceed the estimated maximal expected allele frequency of a pathogenic FOXRED1 variant (0.00125). This variant has been reported in literature in one patient with mitochondrial complex I deficiency in compound heterozygous state with p.R136W variant. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as likely pathogenic/pathogenic. Taken together, this variant is classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at